Brokerages expect CryoPort Inc (NASDAQ:CYRX) to report earnings of ($0.08) per share for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for CryoPort’s earnings. The lowest EPS estimate is ($0.09) and the highest is ($0.07). CryoPort also posted earnings of ($0.08) per share in the same quarter last year. The firm is expected to issue its next quarterly earnings results on Wednesday, November 7th.

On average, analysts expect that CryoPort will report full year earnings of ($0.34) per share for the current fiscal year, with EPS estimates ranging from ($0.36) to ($0.30). For the next year, analysts expect that the company will report earnings of ($0.09) per share, with EPS estimates ranging from ($0.16) to ($0.01). Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that cover CryoPort.

CryoPort (NASDAQ:CYRX) last issued its quarterly earnings data on Thursday, August 9th. The consumer goods maker reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). The firm had revenue of $4.63 million for the quarter, compared to analyst estimates of $4.36 million. CryoPort had a negative return on equity of 45.60% and a negative net margin of 62.80%. The firm’s revenue for the quarter was up 58.6% on a year-over-year basis.

CYRX has been the topic of a number of analyst reports. BidaskClub cut shares of CryoPort from a “buy” rating to a “hold” rating in a research note on Wednesday, August 15th. Cowen raised their price objective on shares of CryoPort from $11.00 to $16.00 and gave the stock an “outperform” rating in a research note on Monday, August 13th. Needham & Company LLC raised their price objective on shares of CryoPort from $11.00 to $19.00 and gave the stock a “buy” rating in a research note on Monday, July 2nd. Finally, Roth Capital raised their price objective on shares of CryoPort from $12.50 to $22.00 and gave the stock a “buy” rating in a research note on Friday, June 29th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $17.25.

In other news, Director Richard J. Berman sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 6th. The shares were sold at an average price of $14.00, for a total transaction of $140,000.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Richard J. Berman sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 15th. The stock was sold at an average price of $12.81, for a total transaction of $256,200.00. The disclosure for this sale can be found here. 9.60% of the stock is owned by company insiders.

Several large investors have recently made changes to their positions in the company. Creative Planning lifted its position in shares of CryoPort by 0.8% during the 2nd quarter. Creative Planning now owns 603,540 shares of the consumer goods maker’s stock valued at $9,524,000 after buying an additional 4,860 shares in the last quarter. D.A. Davidson & CO. lifted its position in shares of CryoPort by 3.7% during the 2nd quarter. D.A. Davidson & CO. now owns 163,260 shares of the consumer goods maker’s stock valued at $2,576,000 after buying an additional 5,860 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of CryoPort by 14.5% during the 1st quarter. Wells Fargo & Company MN now owns 53,990 shares of the consumer goods maker’s stock valued at $464,000 after buying an additional 6,855 shares in the last quarter. Strs Ohio purchased a new position in shares of CryoPort during the 2nd quarter valued at approximately $115,000. Finally, Metropolitan Life Insurance Co. NY purchased a new position in shares of CryoPort during the 2nd quarter valued at approximately $136,000. Hedge funds and other institutional investors own 48.53% of the company’s stock.

Shares of NASDAQ CYRX traded up $0.03 during midday trading on Tuesday, reaching $12.51. 169,800 shares of the stock were exchanged, compared to its average volume of 276,672. The stock has a market capitalization of $355.54 million, a price-to-earnings ratio of -37.09 and a beta of 1.15. CryoPort has a twelve month low of $6.02 and a twelve month high of $16.88.

About CryoPort

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

Further Reading: Why do companies issue stock splits?

Get a free copy of the Zacks research report on CryoPort (CYRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.